Skip Navigation

Long-term Follow-up Study for Participants Previously Treated with Ciltacabtagene Autoleucel

Brief Summary

Type:
Multiple Myeloma

Study Type:
Supportive Care

Phase:
IV

ClinicalTrials.gov Identifier:
NCT05201781

Study #:
STUDY00150521

Start Date:
Feb 15, 2024

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT05201781

View Complete Trial Details & Eligibility at ClinicalTrials.gov